Motilium (Motis)

Motilium contains the active ingredient domperidone, a dopamine receptor antagonist that belongs to the class of prokinetic and antiemetic agents. It has been used across Europe and many other countries since the 1970s for the management of nausea, vomiting, and upper gastrointestinal symptoms associated with slow stomach emptying. While domperidone is not marketed in the United States, it remains widely available internationally and is prescribed under strict guidelines established by the EMA.

How Motilium Works

Domperidone acts by selectively blocking dopamine D2 and D3 receptors in the peripheral nervous system. It targets two key areas: the wall of the gastrointestinal tract and the chemoreceptor trigger zone (CTZ) located in the area postrema of the brain, which sits outside the blood-brain barrier. By blocking dopamine receptors in the gut, domperidone increases esophageal and gastric peristalsis, lowers esophageal sphincter pressure, and accelerates gastric emptying. At the CTZ it suppresses the signals that trigger the nausea and vomiting reflex. Because domperidone has very limited penetration into the central nervous system compared to other dopamine antagonists, it carries a lower risk of causing the extrapyramidal side effects (such as tremor or involuntary movements) that are sometimes seen with drugs like metoclopramide.

Dosing and Administration

The recommended dose of Motilium for adults and adolescents aged 12 years and older who weigh at least 35 kg is one 10 mg tablet taken up to three times daily. The maximum recommended daily dose is 30 mg according to current EMA guidelines, though some product information permits up to 40 mg per day (one tablet four times daily) when clinically necessary. Tablets should be taken 15 to 30 minutes before meals, as taking domperidone after eating can delay absorption. For acute nausea and vomiting, treatment should generally not continue beyond one week. If symptoms persist beyond seven days patients should consult their doctor for further evaluation. Patients with severe kidney problems may need to reduce their dosing frequency to once or twice daily, and those with moderate to severe liver impairment should not use this medication at all.

Clinical Effectiveness

Domperidone has shown clinical effectiveness in relieving symptoms of dyspepsia and functional gastrointestinal disorders. Multiple controlled trials included in the Motilium product database evaluated over 1,200 patients with gastroparesis, dyspepsia, and gastroesophageal reflux symptoms. The EMA’s review confirmed sufficient evidence supporting the use of oral domperidone 10 mg up to three times a day for the general treatment of nausea and vomiting in adults. Patients dealing with digestive discomfort may also want to explore other digestive health medications available through our pharmacy. For those managing gastroparesis related to diabetes, understanding the connection between blood sugar control and gastric function is helpful — our guide on prediabetes and type 2 diabetes covers the basics of how these conditions develop.

Important Safety Considerations

In 2014 the EMA completed a thorough review of domperidone after ongoing reports of cardiac side effects. The review concluded that domperidone-containing medicines should remain available but with tighter restrictions. The agency restricted its approved use to nausea and vomiting only, removing prior indications for bloating and heartburn. Treatment duration was capped at one week and the maximum daily dose was reduced. Domperidone has been associated with a small increased risk of QT interval prolongation on electrocardiogram, and in very rare cases this has led to serious ventricular arrhythmias or sudden cardiac death. This risk appears to be higher in patients over 60 years of age and in those taking daily doses above 30 mg. Patients with underlying heart conditions, electrolyte imbalances (such as low potassium or magnesium), or those taking other medications that prolong the QT interval should not use Motilium.

Drug Interactions

Domperidone is primarily metabolized through the CYP3A4 enzyme pathway. Taking it together with strong CYP3A4 inhibitors — including certain azole antifungals (ketoconazole, itraconazole, voriconazole), macrolide antibiotics (clarithromycin, erythromycin), and HIV protease inhibitors (ritonavir, saquinavir) — is contraindicated because these drugs increase domperidone blood levels and may raise the risk of cardiac effects. Medications known to prolong the QT interval, such as certain antiarrhythmics, antipsychotics, and some antidepressants, must also be avoided. Patients using Nexium or other proton pump inhibitors should be aware that antacids and antisecretory agents can reduce domperidone absorption and should ideally be taken after meals rather than at the same time as Motilium. For patients who experience nausea as a side effect of their antidepressant medications, domperidone may sometimes be considered, but only after careful review of potential drug interactions by a healthcare provider.

Pregnancy, Breastfeeding, and Special Populations

Motilium is not recommended during pregnancy due to limited safety data in pregnant women. Animal studies have shown reproductive toxicity at high doses, so the drug should only be used when the expected benefit clearly outweighs the potential risk. Although only a very small amount of domperidone passes into breast milk (estimated at about 0.1% of the maternal dose), breastfeeding is not recommended during treatment because potential cardiac effects in the infant cannot be ruled out. Patients with mild liver impairment do not require dose adjustments, but those with moderate or severe hepatic problems must not take this medication. If you’re looking to order medication online from a trusted source, you can buy Motilium through our online pharmacy and have it delivered directly to your door.

Storage

Store Motilium tablets below 30°C in a dry place, protected from light. Keep the medication in its original packaging until ready to use and out of the reach of children. Do not use the tablets after the expiration date printed on the packaging.